67 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
and additional losses recorded for the supply agreement litigation with AbbVie, Inc. (AbbVie) in the current period, partially offset by a decrease … the restructuring expenses JPY 60,130 million, additional losses recorded for the supply agreement litigation with AbbVie, Inc. (AbbVie) in the current
6-K
TAK
Takeda Pharmaceutical Co
1 Feb 24
Current report (foreign)
6:06am
litigation with AbbVie, Inc. (AbbVie) in the current period, partially offset by a decrease in valuation reserve for pre-launch inventories.
Operating Profit … December 31, 2023.
AbbVie Supply Agreement Litigation
In November 2020, AbbVie brought suit against Takeda Pharmaceutical Company Limited (“Takeda
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
for litigation 38,283 28,754 Tools and fixtures 8,492 6,783 Reserve for share-based payments 2,548 2,703 Land 39,794 39,196 Reserve for restructuring
6-K
EX-99.1
uiqz0aen6k1njd4x
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
usbkujos96oc4ex
30 May 23
Current report (foreign)
6:11am
6-K
j32d5h7ynp
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
jx76wb1 ps45
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
fiu5ti7tm 5qa
31 May 22
Current report (foreign)
12:00am
6-K
en4v xu91n
10 Feb 22
Current report (foreign)
6:03am
6-K
EX-99.1
ztp5fp2koe9
11 Jan 22
Current report (foreign)
6:02am
6-K
8m9zbt5i
5 Nov 21
Current report (foreign)
6:02am
6-K
dc4kve3lzkh 29bi
6 Aug 21
Current report (foreign)
6:06am
6-K
EX-99.1
87jxyu5ia
28 May 21
Current report (foreign)
6:03am
6-K
EX-99.1
b49o b86ody2d95
28 May 21
Current report (foreign)
6:01am
6-K
EX-99.1
rix96o1vel4kd3th sg
17 Dec 20
Current report (foreign)
6:01am